Special UCL-Eisai Neurodegenerative Disease Drug Development Partnership Extended Again
July 01, 2026
July 01, 2026
LONDON, England, July 1 -- The University College London posted the following news:
* * *
Special UCL-Eisai neurodegenerative disease drug development partnership extended again
A special partnership between UCL and a Japanese pharmaceutical firm which is investigating new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's has been extended to 2030.
University College London (UCL) and Eisai Co., Ltd. (Headqu . . .
* * *
Special UCL-Eisai neurodegenerative disease drug development partnership extended again
A special partnership between UCL and a Japanese pharmaceutical firm which is investigating new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's has been extended to 2030.
University College London (UCL) and Eisai Co., Ltd. (Headqu . . .